Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In a previous article we reported that mutations favoring cancer at adulthood seemed to improve fertility and limit miscarriages. Because spontaneous abortion may result from anomalies in embryo, we questioned if an increased frequency of congenital malformation could be evidenced among cancer-prone families. Oncogenetics database (≈193 000 members) of the comprehensive cancer center Jean Perrin was crossed with regional registry of congenital malformations (≈10 000). Among children born between 1986 and 2011, 176 children with malformation matched in both databases. In breast/ovaries cancer-prone families, the risk for malformations was multiplied by 2.4 [1.2-4.5] in case of a BRCA1 mutation. Frequencies of malformation in BRCA2 and MMR mutated families were similar to families without a cancer syndrome. In comparison to malformations concerning a unique anatomical system, multimalformations were significantly more frequent in case of BRCA or MMR mutations: compared to families without cancer syndrome, the risk of multimalformations was multiplied by 4.1 [0.8-21.7] for cancer-prone families but with no known deleterious mutation, by 6.9 [1.2-38.6] in families with a known mutation but an unknown parental mutational status and by 10.4 [2.3-46.0] when one parent carried the familial mutation. No association with the type of anatomical system was found, nor with multiple births. These results suggest that BRCA and MMR genes play an important role in human embryogenesis and that if their function is lowered because of heterozygote mutations, congenital malformations are either more likely (BRCA1 mutations) and/or more susceptible to concern several anatomical systems.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973007PMC
http://dx.doi.org/10.1111/cga.12329DOI Listing

Publication Analysis

Top Keywords

cancer-prone families
12
congenital malformations
8
families cancer
8
cancer syndrome
8
anatomical system
8
brca mmr
8
families
7
association hereditary
4
hereditary predisposition
4
predisposition common
4

Similar Publications

Chronic inflammation is a key driver of cancer. Interleukin 33 (IL-33) has emerged as a crucial factor involved in the pathogenesis of cancer-prone chronic inflammation. IL-33 functions as a cytokine and a nuclear protein to initiate chronic inflammation and cancer.

View Article and Find Full Text PDF

A "rotating menu" of medical uncertainty for families affected by telomere biology disorders: A qualitative interview study.

SSM Qual Res Health

December 2024

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Background: Medical uncertainty may cause distress and challenge medical decision-making for patients with rare diseases and their caregivers. Few studies have examined the experience and management of medical uncertainty in rare disease and the dynamics of multiple medical uncertainty sources, issues, and management strategies.

Objective: We explored the experience and management of uncertainty in individuals with telomere biology disorders (TBDs), a set of rare cancer-prone bone marrow failure syndromes, and their caregivers.

View Article and Find Full Text PDF

Canonical and Non-Canonical Roles of Human DNA Polymerase η.

Genes (Basel)

September 2024

DNA Damage Response Laboratory, Centre for Chromosome Biology, School of Biological and Chemical Sciences, University of Galway, Galway H91W2TY, Ireland.

DNA damage tolerance pathways that allow for the completion of replication following fork arrest are critical in maintaining genome stability during cell division. The main DNA damage tolerance pathways include strand switching, replication fork reversal and translesion synthesis (TLS). The TLS pathway is mediated by specialised DNA polymerases that can accommodate altered DNA structures during DNA synthesis, and are important in allowing replication to proceed after fork arrest, preventing fork collapse that can generate more deleterious double-strand breaks in the genome.

View Article and Find Full Text PDF

Understanding genetic variations associated with familial breast cancer.

World J Surg Oncol

October 2024

Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.

Article Synopsis
  • - Breast cancer is the most common cancer in women, with genetics accounting for 15-25% of cases, primarily involving mutations in genes like BRCA1 and BRCA2.
  • - A comprehensive review of 768 articles identified 20 familial breast cancer-associated genes categorized by their penetrance levels and uncovered 10 genetic disorders related to the disease.
  • - The National Comprehensive Cancer Network recommends genetic screening, focusing on high- and moderate-risk gene variations, and highlights the potential of next-generation sequencing (NGS) to uncover rare genetic links to breast cancer.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic inflammation is a significant factor in the development of cancer, with interleukin 33 (IL-33) being a key player in this process, though its environmental triggers remain unclear.
  • A study reveals that the TLR3/4-TBK1-IRF3 signaling pathway links environmental stressors to the induction of IL-33 in skin and pancreatic inflammation.
  • Pitavastatin, an FDA-approved drug, effectively reduces IL-33 levels and demonstrates the potential to prevent chronic pancreatitis and its associated cancer through inhibiting the TBK1 pathway, suggesting statins may be a promising approach to combat chronic inflammation-related cancers.
View Article and Find Full Text PDF